When a person is diagnosed with Type 1 diabetes (T1D), the amount of beta–cell mass each individual loses is highly variable despite their clinical need for insulin therapy. Attempts to detect robust markers in the blood that precisely describe disease activity in the islets are ongoing, but without a full understanding of the disease course […]